We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > AmpliPhi Biosciences

News List

C3J Therapeutics and AmpliPhi Biosciences Announce Successful Completion of Merger and Formation of Bacteriophage Company Armata Pharmaceuticals, Inc. firstwordpharma
May 10, 2019
Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata"), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections ...
AmpliPhi Biosciences and C3J Therapeutics Agree to Merge pharmafocusasia
January 08, 2019
AmpliPhi Biosciences Corporation, a clinical-stage biotechnology company focused on the development of precisely targeted bacteriophage therapeutics for antibiotic-resistant infections .....
AmpliPhi Biosciences Announces Presentation of Preclinical Data Demonstrating that AB-PA01 Reduces B biospace
March 12, 2018
AmpliPhi Biosciences Corporation today announced the presentation of in vivo preclinical data showing AB-PA01 reduces biofilm in a Pseudomonas